Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial

Brenda Gibson(Royal Hospital for Children), Keith Wheatley(Cancer Research UK Clinical Trials Unit), Andrew Howman(Cancer Research UK Clinical Trials Unit), Christine J. Harrison(Newcastle University), David Webb(Royal Hospital for Children), Siebold S.N. de Graaf(Royal Hospital for Children)
British Journal of Haematology
September 9, 2011
10.1111/j.1365-2141.2011.08851.x
Cited by 205

Related Papers

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
|Blood|2006|746
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
|Blood|2009|494
Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
|Journal of Clinical Oncology|2013|415
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383